Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China · Delayed Price · Currency is CNY 40.42
-0.03 (-0.07%)
Sep 14, 2026, 4:00 PM EDT
SHE:301108 Revenue
Tongling Jieya Biologic Technology had revenue of 226.68M CNY in the quarter ending June 30, 2026, with 21.56% growth. This brings the company's revenue in the last twelve months to 880.78M, up 53.85% year-over-year. In the year 2025, Tongling Jieya Biologic Technology had annual revenue of 772.01M with 41.02% growth.
Revenue (ttm)
880.78M
Revenue Growth
+53.85%
P/S Ratio
5.17
Revenue / Employee
1.39M
Employees
634
Market Cap
4.55B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 772.01M | 224.56M | 41.02% |
| Dec 31, 2024 | 547.45M | -75.14M | -12.07% |
| Dec 31, 2023 | 622.59M | -43.98M | -6.60% |
| Jan 1, 2023 | 666.56M | -317.89M | -32.29% |
| Jan 1, 2022 | 984.45M | 241.44M | 32.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.